Saltar al contenido
Merck

mAbs Downstream

Products for Development and Manufacturing

 

Higher cell densities and antibody titers from increasingly advanced upstream processes result in complex downstream purification challenges. The downstream workflow, which includes clarification, chromatography, concentration, viral clearance, and sterile filtration steps, is essential for ensuring monoclonal antibody (mAb) product quality, yield, safety, and sterility. 


Procesamiento Downstream

Maximize Productivity of Downstream Bioprocessing

The downstream process consists of many purification and filtration unit operations, each of which must be robust, scalable, and optimized to mitigate loss of the monoclonal antibody (mAb) and maximize product yield.

Combine these technologies with our application expertise to overcome any downstream processing challenge.

 


Categorías relacionadas

A female scientist wearing protective goggles holds up a sterile drug product.
Filtros esterilizantes

Sterile filtration is crucial for bacterial removal in drug production and bioprocessing.

Affinity chromatography with Eshmuno® resins
Resinas para cromatografía de afinidad

Our range of affinity resins are designed for high throughput and cost-effective purification.

Ion Exchange Resins
Resinas para cromatografía de intercambio iónico

Our AEX and CEX resins offer efficient purification solutions for mAbs, and other modalities.

Sistemas cromatográficos para bioprocesamiento

From pilot to process-scale, our chrom systems are designed to provide robust, consistent performance.

Cuentagotas transfiriendo líquido en el proceso de anticuerpos monoclonales
Eliminación de virus

Our viral clearance portfolio includes the virus filtration solutions, chemicals, holders and systems.

Solución Mobius® FlexReady para TFF
Ultrafiltración y diafiltración

Ultrafiltration & diafiltration increase capacity, concentration, and recovery in bioprocessing.


Recursos relacionados

Página 1 de 3


Explores nuestras soluciones

Inicie sesión para continuar.

Para seguir leyendo, inicie sesión o cree una cuenta.

¿No tiene una cuenta?